Insider Buy/Sell Details for the Healthcare Sector — January 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1606)
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
19
Price
$375.65
Total Value
$7.14K
Shares Held After
29,743
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
14
Price
$374.44
Total Value
$5.24K
Shares Held After
29,762
% of Holdings
0.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
2
Price
$372.46
Total Value
$744.92
Shares Held After
29,776
% of Holdings
0.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
19
Price
$370.87
Total Value
$7.05K
Shares Held After
29,778
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
40
Price
$369.48
Total Value
$14.78K
Shares Held After
29,797
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
92
Price
$368.62
Total Value
$33.91K
Shares Held After
29,837
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
41
Price
$367.40
Total Value
$15.06K
Shares Held After
29,929
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
50
Price
$366.41
Total Value
$18.32K
Shares Held After
29,970
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
220
Price
$365.56
Total Value
$80.42K
Shares Held After
30,020
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
199
Price
$364.83
Total Value
$72.60K
Shares Held After
30,240
% of Holdings
0.7%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
47
Price
$363.55
Total Value
$17.09K
Shares Held After
30,439
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
73
Price
$362.38
Total Value
$26.45K
Shares Held After
30,486
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
98
Price
$361.45
Total Value
$35.42K
Shares Held After
30,559
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
155
Price
$360.22
Total Value
$55.83K
Shares Held After
30,657
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
85
Price
$359.14
Total Value
$30.53K
Shares Held After
30,812
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
123
Price
$358.18
Total Value
$44.06K
Shares Held After
30,897
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
96
Price
$357.17
Total Value
$34.29K
Shares Held After
31,020
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
41
Price
$356.09
Total Value
$14.60K
Shares Held After
31,116
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
42
Price
$355.16
Total Value
$14.92K
Shares Held After
31,157
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
39
Price
$353.95
Total Value
$13.80K
Shares Held After
31,199
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
15
Price
$377.82
Total Value
$5.67K
Shares Held After
23,554
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
19
Price
$375.65
Total Value
$7.14K
Shares Held After
23,569
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
14
Price
$374.44
Total Value
$5.24K
Shares Held After
23,588
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
2
Price
$372.46
Total Value
$744.92
Shares Held After
23,602
% of Holdings
0.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
19
Price
$370.87
Total Value
$7.05K
Shares Held After
23,604
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
40
Price
$369.48
Total Value
$14.78K
Shares Held After
23,623
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
92
Price
$368.62
Total Value
$33.91K
Shares Held After
23,663
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
41
Price
$367.40
Total Value
$15.06K
Shares Held After
23,755
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
50
Price
$366.41
Total Value
$18.32K
Shares Held After
23,796
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
220
Price
$365.56
Total Value
$80.42K
Shares Held After
23,846
% of Holdings
0.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
199
Price
$364.83
Total Value
$72.60K
Shares Held After
24,066
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
47
Price
$363.55
Total Value
$17.09K
Shares Held After
24,265
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
73
Price
$362.38
Total Value
$26.45K
Shares Held After
24,312
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
98
Price
$361.45
Total Value
$35.42K
Shares Held After
24,385
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
155
Price
$360.22
Total Value
$55.83K
Shares Held After
24,483
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
85
Price
$359.14
Total Value
$30.53K
Shares Held After
24,638
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
123
Price
$358.18
Total Value
$44.06K
Shares Held After
24,723
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
96
Price
$357.17
Total Value
$34.29K
Shares Held After
24,846
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
41
Price
$356.09
Total Value
$14.60K
Shares Held After
24,942
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
42
Price
$355.16
Total Value
$14.92K
Shares Held After
24,983
% of Holdings
0.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Fitzgerald Kevin Joseph — CSO & EVP, Head of Research
Shares
39
Price
$353.95
Total Value
$13.80K
Shares Held After
25,025
% of Holdings
0.2%
Immuneering Corp (IMRX)
Feinberg Peter — Director
Shares
20,000
Price
$4.35
Total Value
$86.90K
Shares Held After
135,441
% of Holdings
14.8%
Greenwich LifeSciences, Inc. (GLSI)
Patel Snehal — Director
Shares
2,900
Price
$27.54
Total Value
$79.87K
Shares Held After
5,602,302
% of Holdings
0.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
7,117
Price
$33.15
Total Value
$235.93K
Shares Held After
639,151
% of Holdings
1.1%
Mineralys Therapeutics, Inc. (MLYS)
Congleton Jon — Director
Shares
9,119
Price
$32.21
Total Value
$293.71K
Shares Held After
646,268
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Levy Adam Scott — CFO and Secretary
Shares
10,758
Price
$32.14
Total Value
$345.72K
Shares Held After
8,638
% of Holdings
55.5%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$32.32
Total Value
$205.14K
Shares Held After
61,804
% of Holdings
9.3%
Orthofix Medical Inc. (OFIX)
Calafiore Massimo — Director
Shares
9,797
Price
$15.21
Total Value
$149.05K
Shares Held After
217,237
% of Holdings
4.3%
Zymeworks Inc. (ZYME)
Hollywood Mark — EVP & Chief Operating Officer
Shares
6,120
Price
$22.67
Total Value
$138.76K
Shares Held After
132,913
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$479.51
Total Value
$3.78M
Shares Held After
0
% of Holdings
100.0%
Showing 751–800 of 1606 transactions (page 16 of 33)